Resumen de acción UPR
Uniphar plc opera como empresa diversificada de servicios sanitarios en la República de Irlanda, el Reino Unido, los Países Bajos y a escala internacional.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 3/6 |
| Resultados anteriores | 2/6 |
| Salud financiera | 4/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Uniphar plc
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | €2.49 |
| Máximo en 52 semanas | €3.23 |
| Mínimo de 52 semanas | €1.98 |
| Beta | 0.75 |
| 11 mes Cambio | -7.78% |
| Variación en 3 meses | -7.09% |
| Cambio de 1 año | -17.82% |
| 3Variación en 3 años | -26.33% |
| Variación en 5 años | n/a |
| Variación desde la OPV | 112.82% |
Noticias y actualizaciones recientes
Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03
Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24
Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Rentabilidad de los accionistas
| UPR | IE Healthcare | Mercado IE | |
|---|---|---|---|
| 7D | 3.1% | -2.9% | 0.2% |
| 1Y | -17.8% | -1.8% | 12.3% |
Rentabilidad vs. Industria: Los resultados de UPR fueron inferiores a los de la industria Irish Healthcare, que obtuvo un rendimiento del -0.4% el año pasado.
Rentabilidad vs. Mercado: UPR obtuvo unos resultados inferiores a los del mercado Irish, que fueron del 10.1% el año pasado.
Volatilidad de los precios
| UPR volatility | |
|---|---|
| UPR Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in IE Market | 5.9% |
| 10% least volatile stocks in IE Market | 2.0% |
Precio estable de las acciones: UPR no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de UPR (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc opera como empresa diversificada de servicios sanitarios en la República de Irlanda, el Reino Unido, los Países Bajos y a escala internacional. La empresa opera a través de tres divisiones: Medtech, Pharma y Supply Chain & Retail. La división Medtech ofrece servicios externalizados de ventas, marketing, distribución y asistencia a fabricantes de productos sanitarios.
Resumen de fundamentos de Uniphar plc
| Estadísticas fundamentales de UPR | |
|---|---|
| Capitalización bursátil | €679.81m |
| Beneficios(TTM) | €44.82m |
| Ingresos (TTM) | €2.55b |
15.2x
Ratio precio-beneficio (PE)0.3x
Ratio precio-ventas (PS)¿Está UPR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de UPR | |
|---|---|
| Ingresos | €2.55b |
| Coste de los ingresos | €2.16b |
| Beneficio bruto | €389.98m |
| Otros gastos | €345.17m |
| Beneficios | €44.82m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.16 |
| Margen bruto | 15.28% |
| Margen de beneficio neto | 1.76% |
| Ratio deuda/patrimonio | 70.7% |
¿Cómo se ha desempeñado UPR a largo plazo?
Ver rendimiento histórico y comparativa